Chart calendar JW Pharmaceutical Corporation

02da40.pUWUeXdXB_9PSR42X3KMy1OdATrPNrZc3385EJYPh4c.9CL_FBkma7YJeGRGFwDGuh7TMEyGAf8opTltJ6IisdL1PfxPWiNfuDs4aQ~3a325678ceaa564d2bdde1b2533f30b7

Upcoming events on JW Pharmaceutical Corporation

2025-08-18 Q2 2025 Earnings Release (Projected)
2025-11-11 Q3 2025 Earnings Release (Projected)
2026-03-23 Q4 2025 Earnings Release (Projected)
2026-05-17 Q1 2026 Earnings Release (Projected)

Past events on JW Pharmaceutical Corporation

2025-05-14 Q1 2025 Earnings Release
2025-03-25 Shareholders Meeting
2025-03-17 Q4 2024 Earnings Release
2024-11-13 Q3 2024 Earnings Release
2024-08-13 Q2 2024 Earnings Release
2024-05-13 Q1 2024 Earnings Release
2024-03-26 Annual General Meeting
2024-03-17 Q4 2023 Earnings Release
2023-05-14 Q1 2023 Earnings Release
2023-03-20 Q4 2022 Earnings Release
2022-11-13 Q3 2022 Earnings Release
2022-08-15 Interim 2022 Earnings Release
2022-05-15 Q1 2022 Earnings Release
2021-08-16 Interim 2021 Earnings Release
2021-05-16 Q1 2021 Earnings Release
2021-03-17 FY 2020 Earnings Release
2020-03-29 FY 2019 Earnings Release
2019-11-13 Q3 2019 Earnings Release
2019-05-14 Q1 2019 Earnings Release
2018-08-13 Interim 2018 Earnings Release

Past dividends on JW Pharmaceutical Corporation

2024-12-26 Annual 450 KRW
2023-12-26 Annual 400 KRW
2022-12-27 Annual 375 KRW
2021-12-28 Annual 325 KRW
2020-12-28 Annual 325 KRW
2019-12-26 Annual 325 KRW
2018-12-26 Annual 325 KRW
2017-12-26 Annual 275 KRW
2016-12-27 Annual 142.857 KRW
2015-12-28 119.0475 KRW
2014-12-28 Annual 125 KRW
2013-12-26 Annual 125 KRW
2012-12-26 Annual 125 KRW
2011-12-27 Annual 200 KRW
2010-12-28 Annual 300 KRW
2009-12-28 Annual 300 KRW
2008-12-28 Annual 300 KRW
2007-12-26 Annual 600 KRW
2006-12-26 Annual 500 KRW
2005-12-27 Annual 500 KRW

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026
Net sales
Billions KRW
Released
Forecast
Spread
684
672
1.84%
750
750
-0.01%
719
716
0.49%

778


838

EBITDA
Billions KRW
Released
Forecast
Spread
79,8
69,0
15.65%
123
115
6.94%
102
114
-10.89%

124


133

EBIT
Billions KRW
Released
Forecast
Spread
64,4
55,0
17.17%
99,6
95,5
4.23%
82,5
86,2
-4.31%

96,9


105

Earnings before Tax (EBT)
Billions KRW
Released
Forecast
Spread
46,4
45,0
3.14%
51,6
56,0
-7.84%
82,4
90,0
-8.42%

103


112

Net income
Billions KRW
Released
Forecast
Spread
33,5
34,0
-1.32%
34,8
44,5
-21.7%
65,0
66,3
-1.9%

78,7


86,0

EPS
KRW
Released
Forecast
Spread
1 305
1 512
-13.72%
1 529
1 851
-17.4%
2 669
2 817
-5.25%

3 350


3 676

Announcement Date08/02/2305/02/2407/02/25-

Quarterly results

Fiscal PeriodMarch 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Billions KRW
Released
Forecast
Spread
184
193
-4.76%
205
209
-1.67%
181
186
-3.14%
172
192
-10.18%
179
205
-12.87%
188
190
-1.34%
185
183
1.11%

187


197


211

EBITDA
Billions KRW
Released
Forecast
Spread









16,4
27,1
-39.56%
31,3
34,2
-8.57%
22,8
38,0
-39.91%












EBIT
Billions KRW
Released
Forecast
Spread
26,1
19,6
32.97%
33,3
27,4
21.67%
26,2
24,0
9.59%
11,6
21,3
-45.35%
26,5
27,6
-3.67%
18,1
20,7
-12.74%
22,0
22,7
-3.05%

25,4


25,6


23,2

Net income
Billions KRW
Released
Forecast
Spread
-17,9
14,5
-223.52%
25,0
29,4
-15.09%
20,1
19,5
3.01%
8,51
17,2
-50.52%
19,8
19,9
-0.02%
16,6
17,5
-5.17%
17,5
17,4
0.41%

20,3


19,2


21,8

Announcement Date14/11/2305/02/2414/05/2414/08/2414/11/2407/02/2515/05/25---

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A001060 Stock
  4. Calendar JW Pharmaceutical Corporation